Etoposide pathway

Pharmacogenetics and Genomics

Volumn 19, Issue 7, 2009, Pages 552-553

  Yang, Jun ^a   Bogni, Alessia ^a   Schuetz, Erin G ^a   Ratain, Mark ^b   Eileen Dolan, M ^b   McLeod, Howard ^c   Gong, Li ^d   Thorn, Caroline ^d   Relling, Mary V ^a   Klein, Teri E ^d   Altman, Russ B ^d,e  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DOUBLE STRANDED DNA; EPIPODOPHYLLOTOXIN DERIVATIVE; ETOPOSIDE; GLUCURONOSYLTRANSFERASE 1A1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; TENIPOSIDE; XENOBIOTIC AGENT; ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; DNA TOPOISOMERASE II ALPHA; MULTIDRUG RESISTANCE PROTEIN; TUMOR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; CONJUGATION; CYTOTOXICITY; DNA STRAND BREAKAGE; DRUG INHIBITION; DRUG METABOLISM; FUSION GENE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; DOUBLE STRANDED DNA BREAK; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DNA BREAKS, DOUBLE-STRANDED; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; ETOPOSIDE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 67651213977     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32832e0e7f     Document Type: Short Survey

References (22)

1. Berger NA, Chatterjee S, Schmotzer JA, Helms SR. Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death. Proc Natl Acad Sci U S A 1991; 88:8740-8743.
2. Relling MV, Nemec J, Schuetz EG, Schuetz JD, Gonzalez FJ, Korzekwa KR. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4. Mol Pharmacol 1994; 45:352-358.
3. Zhuo X, Zheng N, Felix CA, Blair IA. Kinetics and regulation of cytochrome P450-mediated etoposide metabolism. Drug Metab Dispos 2004; 32:993-1000.
4. Luo G, Guenthner T, Gan LS, Humphreys WG. CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr Drug Metab 2004; 5:483-505.
5. Kishi S, Yang W, Boureau B, Morand S, Das S, Chen P, et al. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood 2004; 103:67-72.
6. Haim N, Roman J, Nemec J, Sinha BK. Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26). Biochem Biophys Res Commun 1986; 135:215-220.
7. Fan Y, Schreiber EM, Giorgianni A, Yalowich JC, Day BW. Myeloperoxidase-catalyzed metabolism of etoposide to its quinone and glutathione adduct forms in HL60 cells. Chem Res Toxicol 2006; 19:937-943.
8. Kagan VE, Kuzmenko AI, Tyurina YY, Shvedova AA, Matsura T, Yalowich JC. Pro-oxidant and antioxidant mechanisms of etoposide in HL-60 cells: role of myeloperoxidase. Cancer Res 2001; 61:7777-7784.
9. Lovett BD, Strumberg D, Blair IA, Pang S, Burden DA, Megonigal MD, et al. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints. Biochemistry 2001; 40:1159-1170.
10. Mans DR, Lafleur MV, Westmijze EJ, Horn IR, Bets D, Schuurhuis GJ, et al. Reactions of glutathione with the catechol, the ortho-quinone and the semi-quinone free radical of etoposide. Consequences for DNA inactivation. Biochem Pharmacol 1992; 43:1761-1768.
11. Hande K, Bennett R, Hamilton R, Grote T, Branch R. Metabolism and excretion of etoposide in isolated, perfused rat liver models. Cancer Res 1988; 48:5692-5695. (Pubitemid 18248127)
12. Wen Z, Tallman MN, Ali SY, Smith PC. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics. Drug Metab Dispos 2007; 35:371-380.
13. Watanabe Y, Nakajima M, Ohashi N, Kume T, Yokoi T. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1. Drug Metab Dispos 2003; 31:589-595.
14. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 1996; 56:988-994. (Pubitemid 26065391)
15. Zelcer N, Saeki T, Reid G, Beijnen JH, Borst P. Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J Biol Chem 2001; 276:46400-46407.
16. Yang J, Bogni A, Cheng C, Bleibel WK, Cai X, Fan Y, et al. Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia. Clin Pharmacol Ther 2008; 84:691-697.
17. Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991; 325:1682-1687.
18. Ratain MJ, Kaminer LS, Bitran JD, Larson RA, Le Beau MM, Skosey C, et al. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood 1987; 70:1412-1417.
19. Super HJ, McCabe NR, Thirman MJ, Larson RA, Le Beau MM, Pedersen-Bjergaard J, et al. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 1993; 82:3705-3711.
20. Zhou Z, Zwelling LA, Ganapathi R, Kleinerman ES. Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbeta. Br J Cancer 2001; 85:747-751.
21. Azarova AM, Lyu YL, Lin CP, Tsai YC, Lau JY, Wang JC, et al. Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Proc Natl Acad Sci U S A 2007; 104:11014-11019.
22. Huang RS, Duan S, Bleibel WK, Kistner EO, Zhang W, Clark TA, et al. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci U S A 2007; 104:9758-9763.